Cite
HARVARD Citation
Langan, E. et al. (2019). Intralesional interleukin‐2: A novel option to maximize response to systemic immune checkpoint therapy in loco‐regional metastatic melanoma. Dermatologic therapy. 32 (3), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Langan, E. et al. (2019). Intralesional interleukin‐2: A novel option to maximize response to systemic immune checkpoint therapy in loco‐regional metastatic melanoma. Dermatologic therapy. 32 (3), p. n/a. [Online].